Reporte zur Charge ZUH201AA

Symptomtext

allergic reaction; Initial information regarding an unsolicited valid non-serious case was received from a pharmacist via Medical Information (Reference number- 00542982) and transmitted to Sanofi on 31-Mar-2021. This case involves a 66 years old patient (age unspecified) who had an allergic reaction (hypersensitivity) when received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot ZUH201AA, expiry date: 30-Jun-2011) via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious allergic reaction (hypersensitivity) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The caller (pharmacist) was requesting a product composition list for Fluzone Quadrivalent from year 2010. The patient reported that she had an allergic reaction after receiving the Fluzone vaccine. The caller has a patient who is interested in getting the coronavirus disease (COVID 19) vaccine. The caller would like to compare the list of ingredients from 2010 Fluzone Quadrivalent to the COVID 19. No laboratory data was provided It was not reported if the patient received a corrective treatment for the event At time of reporting, the outcome of event was unknown.